Abstract
Mechanistic static modeling predicts low risk of unconjugated hyperbilirubinemia due to UGT1A1 inhibition by pirtobrutinib 200 mg once daily
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
